Three-Drug attack on tough liver cancer
NCT ID NCT07052253
Summary
This study is testing a new combination of three drugs (AK104, AK112, and TT-00420) for people with advanced liver cancer that cannot be treated with surgery. The main goal is to see how well the combination shrinks tumors and controls the disease. It will involve about 100 participants who have not had prior drug treatment for their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital Tongji Medical College Huazhong University of Science And Technology
RECRUITINGWuhan, China, 430000, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.